SUBRAMANIAN SANJAY (SVP, CFO) reported 1 transaction at INOZYME PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/3/2025ACC: 0000950170-25-094103
Officer· SVP, CFO
Since Mar 2022
-538.20K
Net shares
Net seller
$158.8K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
538.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−39.70K
Price / share
$4.00
Trade value
$158.80K
% of position
New position
7/1/2025
39.70K→0.00
Total
Net shares
−39.70K
Net value
-$158.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | U · U | −39.70K | $4.00 | $158.80K | New position | 39.70K | 0.00 |
| Total | −39.70K | -$158.80K | ||||||
Derivative Transactions4
Restricted Stock Units
Direct
Converts to
Common Stock
38.50K shares
Shares
−38.50K
Strike price
Held after
0.00
Exercisable
—
7/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
180K shares
Shares
−180K
Strike price
3.96
Held after
0.00
Exercisable
—
7/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
135K shares
Shares
−135K
Strike price
3.30
Held after
0.00
Exercisable
—
7/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
145K shares
Shares
−145K
Strike price
1.06
Held after
0.00
Exercisable
—
7/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock38.50K shares | 7/1/2025 | D · Disposition | −38.50K | — | 0.00 | |
| Stock Option (Right to Buy) Direct | Common Stock180K shares | 7/1/2025 | D · Disposition | −180K | 3.96 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock135K shares | 7/1/2025 | D · Disposition | −135K | 3.30 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock145K shares | 7/1/2025 | D · Disposition | −145K | 1.06 | — | 0.00 |